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ABSTRACT The emerging bunyavirus Rift Valley fever virus (RVFV) is transmitted to
humans and livestock by a large number of mosquito species. RNA interference
(RNAi) has been characterized as an important innate immune defense mechanism
used by mosquitoes to limit replication of positive-sense RNA ﬂaviviruses and toga-
viruses; however, little is known about its role against negative-strand RNA viruses
such as RVFV. We show that virus-speciﬁc small RNAs are produced in infected mos-
quito cells, in Drosophila melanogaster cells, and, most importantly, also in RVFV vec-
tor mosquitoes. By addressing the production of small RNAs in adult Aedes sp. and
Culex quinquefasciatus mosquitoes, we showed the presence of virus-derived Piwi-
interacting RNAs (piRNAs) not only in Aedes sp. but also in C. quinquefasciatus mos-
quitoes, indicating that antiviral RNA interference in C. quinquefasciatus mosquitoes
is similar to the described activities of RNAi in Aedes sp. mosquitoes. We also show
that these have antiviral activity, since silencing of RNAi pathway effectors enhances
viral replication. Moreover, our data suggest that RVFV does not encode a suppres-
sor of RNAi. These ﬁndings point toward a signiﬁcant role of RNAi in the control of
RVFV in mosquitoes.
IMPORTANCE Rift Valley fever virus (RVFV; Phlebovirus, Bunyaviridae) is an emerging
zoonotic mosquito-borne pathogen of high relevance for human and animal health.
Successful strategies of intervention in RVFV transmission by its mosquito vectors
and the prevention of human and veterinary disease rely on a better understanding
of the mechanisms that govern RVFV-vector interactions. Despite its medical impor-
tance, little is known about the factors that govern RVFV replication, dissemination,
and transmission in the invertebrate host. Here we studied the role of the antiviral
RNA interference immune pathways in the defense against RVFV in natural vector
mosquitoes and mosquito cells and draw comparisons to the model insect Drosoph-
ila melanogaster. We found that RVFV infection induces both the exogenous small
interfering RNA (siRNA) and piRNA pathways, which contribute to the control of viral
replication in insects. Furthermore, we demonstrate the production of virus-derived
piRNAs in Culex quinquefasciatus mosquitoes. Understanding these pathways and the
targets within them offers the potential of the development of novel RVFV control
measures in vector-based strategies.
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Rift Valley fever (RVF; Phlebovirus, Bunyaviridae) is an important viral zoonosis inAfrica. Rift Valley fever virus (RVFV) infection causes high fever, anorexia, and acute
deaths in young ruminants and abortions in pregnant animals (1–3). In humans,
symptoms are usually mild but infection can lead to retinitis, encephalitis, and hem-
orrhagic fevers. The case fatality rates have varied between epidemics but have
averaged 1% overall (4–6).
RVFV was detected in at least 30 different mosquito species, of which several are
known to transmit the virus (7), which complicates risk assessment of the spread of
RVFV into new areas. Due to both the variety of vectors and the paucity of genetic tools
for their analysis, the interaction between the vector and RVFV remains poorly char-
acterized.
RVFV is encoded by a tripartite negative-sense or ambisense RNA genome. The large
(L) segment encodes the RNA-dependent RNA polymerase. The medium (M) segment
encodes the nonstructural protein NSm and envelope glycoproteins Gn and Gc as well
as a 78-kDa protein and a 14-kDa protein which are expressed from alternative start
codons (8). The small (S) segment encodes the nucleocapsid protein (N) and the
nonstructural protein (NSs). These two proteins are expressed in an ambisense manner
where the N protein is translated from an mRNA transcribed from the genomic RNA
whereas the NSs protein is translated from an mRNA transcribed from the antigenomic
S RNA (9, 10).
Competent vectors not only must allow virus infection and dissemination to saliva
but also must control the adverse effects of virus replication. It is widely accepted that
one key arthropod antiviral pathway is the exogenous small interfering RNA (exo-
siRNA) pathway. Pioneering work in Drosophila melanogaster has demonstrated that
this RNA interference (RNAi) pathway is initiated by the recognition and cleavage of
double-stranded RNA (dsRNA) such as viral replication intermediates and possibly
secondary RNA structures in the cytoplasm by the RNase III enzyme dicer-2 (Dcr2). This
leads to production of 21-nucleotide (nt) virus-derived small interfering RNAs (viRNAs)
and the sequence-speciﬁc degradation of viral genomes or transcription products by
the multiprotein RNA-induced silencing complex (RISC), of which Argonaute-2 (Ago2) is
the major component (11, 12). Orthologues of Dcr2 and Ago2 have also been identiﬁed
in mosquitoes (13), and viRNAs have been shown to be produced in response to
infection of mosquitoes with positive-strand RNA viruses of the Togaviridae and Flavi-
viridae families (14–16) but also for RVFV and other viruses in the Bunyaviridae family
(17–19). Beyond induction of viRNAs, knockdown studies of RNAi proteins have shown
that this pathway directly mediates antiviral activity (16, 20–23). Some viruses have
evolved means to efﬁciently counteract the siRNA response. Viral suppressors of RNA
silencing (VSRs) are diverse in sequence and mode of action and have been described
for plant and insect viruses. For example, the NSs protein of the plant-infecting
Tospovirus Tomato spotted wilt virus (TSWV; Bunyaviridae), the B2 protein of the insect
ﬂock house virus (FHV; Nodaviridae), and the VP3 protein of the mosquito-speciﬁc Culex
Y virus (CYV; Birnaviridae) have been shown to sequester dsRNA molecules of different
lengths, thereby inhibiting Dcr2-mediated cleavage of long dsRNAs into siRNAs and
incorporation of small dsRNA species into RISC (19, 24–26). The dengue virus (DENV)
NS4B protein was shown to have VSR activity. While it could not bind to dsRNAs, it
interfered with dicing (27). A second arbovirus-targeting RNAi pathway is the Piwi-
interacting RNA (piRNA) pathway. D. melanogaster and mosquito piRNAs are 24 to 29 nt
in length and show a characteristic molecular signature (28–30). In D. melanogaster,
piRNAs control the expression of transposons in germline cells and ovarian follicle cells
and thereby help to sustain genomic integrity (28). They are generated in a Dicer-
independent manner; instead, the piRNA pathway relies on Argonaute-3 (Ago3), Au-
bergine (Aub), and Piwi (28, 31, 32). Proposed mechanisms for piRNA production are
the primary processing pathway and the so-called ping-pong ampliﬁcation loop (33).
Long single-stranded precursor RNAs are transcribed from piRNA clusters in the ge-
nome (28) and are processed to primary piRNAs via an unknown mechanism. Primary
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piRNAs are loaded into Aub and Piwi proteins to form so-called piRNA-induced
silencing complexes (piRISCs) (34).
Interestingly, the Piwi protein clade has undergone an expansion in Aedes sp. and
Culex sp. mosquitoes in contrast to D. melanogaster, which points to a diversiﬁcation of
piRNA pathway functions in mosquitoes besides transposon expression control. A. ae-
gypti encodes seven Piwi proteins (Piwi1 to Piwi7) and Ago-3, which are sufﬁcient to
facilitate the production piRNAs and fulﬁll all functions of the pathway in A. aegypti
despite the absence of Aub expression in these mosquitoes (13, 22). Arbovirus-speciﬁc
piRNAs have been found in Aedes sp. mosquitoes and derived cells for a variety of
arboviruses, including ﬂaviviruses (DENV), alphaviruses (Sindbis virus [SINV], chikungu-
nya virus, and Semliki Forest virus [SFV]), and bunyaviruses (29, 30, 35). However, how
virus infection triggers piRNA production remains poorly understood. A recent study
has given some insight into the mechanism of virus-derived synthesis of piRNAs in
mosquito cells (36). Silencing of Piwi5 and Ago3 led to a signiﬁcant reduction of
secondary piRNAs in Sindbis virus (SINV, Togaviridae)- and DENV (Flaviviridae)-infected
mosquito cells, which points to a functional role of these proteins in the ping-pong
ampliﬁcation cycle (36, 37). While Piwi5 was primarily associated with viral negative-
strand-derived piRNAs with a U1 bias, Ago3 preferentially bound viral positive-strand-
derived piRNAs, most of which displayed an A10 bias. It is therefore likely that Piwi5 and
Ago3 act in tandem to generate virus-derived piRNAs. Further, silencing of Piwi4 in
Semliki Forest virus (SFV, Togaviridae)- and Bunyamwera virus (BUNV, Bunyaviridae)-
infected mosquito cells was shown to lead to increased viral replication, indicating that
the piRNA pathway mediates antiviral activity (18, 22). The presence of RVFV-speciﬁc
viRNAs and piRNAs in RVFV-infected mosquito cells and of viRNAs in D. melanogaster
cells (17, 38) suggests an involvement of RNAi pathways also in the control of RVFV
replication; however, their antiviral activity has not been conﬁrmed.
In this study, we analyzed the induction and contribution of small-RNA pathways in
controlling RVFV infection in multiple insect systems. Our results show that RVFV-
speciﬁc small RNAs are produced in response to infection in several mosquito vector
species, mosquito-derived cells, and D. melanogaster cells. We conﬁrm that these act
antivirally by silencing key proteins of the exogenous siRNA pathway in both A. aegypti
Aag2 and D. melanogaster S2 cells and the piRNA pathway in Aag2 cells and through
the use of luciferase-based, small-RNA-speciﬁc sensor constructs. Further to this, we
found no experimental evidence for the presence of an RVFV suppressor of RNA
silencing in the Aag2 and S2 cell systems.
RESULTS
Small-RNA production in RVFV-infected mosquito cells and D. melanogaster
cells. To perform a comparative analysis of small-RNA pathways for RVFV infection in
different insects, we set out to conﬁrm that two key markers of an antiviral RNAi
response occurred: (i) production of viral small RNAs and (ii) increased viral replication
following knockdown of small-RNA pathway mediator proteins in A. aegypti and
D. melanogaster cell lines. We infected A. aegypti-derived Aag2 cells and D. melano-
gaster S2 cells with RVFV strain MP12 and then carried out Illumina next-generation
sequencing and analyzed the small-RNA fractions (Aag2 cells 24 h postinfection [p.i.],
Fig. 1A; S2 cells 96 h p.i., Fig. 1B). We observed an enrichment of reads matching the
RVFV MP12 genomic and antigenomic sequences at 21 to 22 nucleotides (nt) in Aag2
and S2 cells, whereas the enrichment of 27-nt to 30-nt sequences occurred exclusively
in Aag2 cells. The 21-nt to 22-nt fraction most likely corresponds to viral siRNAs or
microRNAs (miRNAs), whereas the 27-nt to 30-nt fraction reﬂects viral piRNAs. ViRNAs
in Aag2 and S2 cells were derived from all three genome segments, with most viRNA
reads per nucleotide matching the M segment sequence followed by the S segment
and the L segment (Fig. 1C and D; see also Table S1 in the supplemental material) and
mapped against viral genome and antigenome in equal ratios (Aag2, 0.98:1; S2, 1.2:1).
Overall viRNA proﬁles in ﬂy and mosquito cells were highly similar, pointing to
conserved viRNA targeting and production in these different insect systems.
Insect RNA Interference Responses against RVFV
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Next, we analyzed whether a piRNA signature was present within the 28-nt small-
RNA reads mapping to the RVFV segments in Aag2 cells. A clear piRNA signature was
found in sequence logos (A10 bias for antigenomic small RNAs and U1 bias for genomic
small RNAs) and a 10-nt overlap of 5=-end genomic and antigenomic small RNAs as
expected for piRNAs produced by the ping-pong ampliﬁcation cycle (Fig. 2A and B). The
28-nt reads were also mapped against all three segments (Fig. 2C). Similarly to 21-nt
viRNA results, coverage showed the read gradient M  S  L (Table S2). The ratio of
genomic reads to antigenomic reads, however, showed an uneven distribution for the
three segments (Table S2). For the M and S segments, we observed a clear enrichment
of 28-nt piRNA-like molecules mapping to the antigenomic sequence. In contrast, a
clear enrichment of genomic sequences was found within the L segment (Table S2).
Virus-derived small-RNA proﬁles in Aedes sp. and Culex quinquefasciatus mos-
quitoes. To verify virus-derived small-RNA production and patterns in RVFV vector
mosquitoes, we infected three different mosquito species (A. aegypti, A. vexans, and
C. quinquefasciatus) which have been associated with RVFV circulation in nature (39)
and analyzed small-RNA proﬁles. RVFV-speciﬁc viRNAs (21 nt) and piRNA-like small
RNAs (24 to 29 nt) were present in infected A. aegypti mosquitoes (Fig. 3A) and
A. vexans mosquitoes (Fig. 3B). In both Aedes mosquito species, representation of
FIG 1 RVFV MP12-infected Aag2 and S2 cells produce virus-speciﬁc small RNAs. (A and B) Small-RNA reads matching the RVFV MP12 genomic/antigenomic
sequences were plotted against the corresponding read lengths (in nucleotides [nt]) for (A) Aag2 cells infected for 24 h and (B) D. melanogaster S2 cells infected
for 96 h prior to small-RNA extraction. (C and D) Alignment of the 21-nt small-RNA reads to the RVFV MP12 sequences of the three RNA segments. The x axis
represents the position of small-RNA reads in reference to the antigenome RNA sequence (5=-to-3= orientation) or the genome orientation (3=-to-5= orientation).
The y axis represents the number of reads for each position, with reads matching the antigenome shown on the positive y axis and reads matching the genome
shown on the negative y axis. (C) Aag2 cells infected for 24 h. (D) D. melanogaster S2 cells infected for 96 h prior to small-RNA extraction.
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FIG 2 RVFV-speciﬁc piRNA-like small RNAs are produced in infected Aedes aegypti Aag2 cells. (A)
Representation of piRNA sequence logos within the 28-nt reads. All reads matching the RVFV MP12
genomic and antigenomic sequences were analyzed for their base frequencies at each position. The
x axis shows the nucleotide position. The y axis represents the frequency of each nucleotide at the
corresponding position. (B) The panel shows the probability of overlap at the 5= end of the opposite viral
small RNA for the 28-nt reads. The x axis indicates the number of nucleotides overlapping between the
antigenomic and genomic sequences; the y axis shows the mean fractions of reads overlapping. (C)
Alignment of the 28-nt small-RNA reads to the RVFV MP12 sequences of the three viral RNA segments.
The x axis represents the position of small-RNA reads in reference to the antigenome RNA sequence
(5=-to-3= orientation) or to the genome (3=-to-5= orientation). The y axis represents the number of reads
for each position, with reads matching the antigenome shown on the positive y axis and reads matching
the genome shown on the negative y axis.
Insect RNA Interference Responses against RVFV
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RVFV-speciﬁc viRNAs reads was equal to or slightly greater than that seen with
piRNA-like small RNAs. Both RVFV-speciﬁc viRNA and piRNA-like small-RNA read num-
bers were very low in infected C. quinquefasciatus mosquitoes (Fig. 3C) compared to
both Aedes species. Similarly to Aag2 cell results, viRNA distribution in either Aedes
species showed an enrichment of reads for the M segment and S segment and low read
numbers for the L segment (Table S1). The relatively low RVFV-speciﬁc small-RNA read
numbers in C. quinquefasciatus did not allow the establishment of a clear distribution
pattern. ViRNAs from all three mosquito species were distributed along the three
segments and mapped against the genome and antigenome (Fig. 3D to F).
As for Aag2 cells, a piRNA signature was found in sequence logos of fragments for
all three mosquito species (Fig. 4A to C) and 5= end overlap of genome and antigenome
28-nt small RNAs (Fig. 4D to F). We also mapped the 28-nt reads from mosquitoes
against the three genomic segments (Fig. 4G to I). Again, we found low coverage of the
L segment; however, levels of coverage of the M and S segments were similar in all
three mosquito species (Table S2). In A. aegyptimosquitoes, 28-nt piRNA-like molecules
showed an enrichment of virus-derived sequences for the antigenomic sequence of the
M segment. The same enrichment of antigenomic M segment sequences was not
observed in A. vexans or C. quinquefasciatus (Table S2). In contrast, targeting of the
antigenomic S segment sequence was a species-independent pattern present in all
three mosquito species as well as Aag2 cells.
Antiviral activity of RVFV-speciﬁc small RNAs. The presence of RVFV-speciﬁc
small RNAs in infected insect cells alone was not indicative of their antiviral activity, as
they might have failed to become incorporated into RISC and might have been unable
to actively target the viral RNA. Therefore, we wanted to conﬁrm the functionality of
virus-derived small RNAs produced during RVFV infection. To do so, small-RNA sensor
constructs consisting of an OpiE2 insect promoter-driven luciferase reporter (nanolu-
ciferase, NLuc) coding sequence fused to different 3= untranslated, noncoding se-
FIG 3 RVFV-derived small RNAs are present in three different vector mosquito species. The small-RNA fraction from RVFV MP12-infected A. aegypti, A. vexans,
and C. quinquefasciatus whole mosquito bodies was isolated 14 days p.i. (A. aegypti and C. quinquefasciatus) or 15 days p.i. (A. vexans) and sequenced (A to C).
The graphs represent the small-RNA reads mapping to the RVFV MP12 genomic and antigenomic sequences. Read numbers per length were plotted for
A. aegypti (A), A. vexans (B), and C. quinquefasciatus (C) against the corresponding read length (in nucleotides) on a linear scale. (D to F) Alignment of the 21-nt
small-RNA reads mapping to the RVFV MP12 sequences of the three RNA segments for all mosquito species as described for RVFV-derived small-RNA reads in
Aag2 cells (Fig. 1C). The alignments for A. aegypti (D), A. vexans (E), and C. quinquefasciatus (F) are shown.
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quences originating from RVFV L and M segment mRNAs as well as N and NSs protein
open-reading frames (ORFs) were used. If RVFV-speciﬁc, functional small RNAs were
present in Aag2 cells following infection with RVFV, NLuc mRNA in the RVFV-speciﬁc
small-RNA sensors would be degraded and NLuc expression reduced. Indeed, a reduc-
tion in luciferase activity was observed in Aag2 cells preinfected with RVFV (Fig. 5A),
whereas luciferase expression from a control sensor containing an enhanced green
ﬂuorescent protein (eGFP) fragment in place of RVFV sequence was unaffected. In
reverse, the ability of the exogenous siRNA machinery to target RVFV RNA during
infection was tested using a recombinant RVFV that expresses humanized Renilla
luciferase (hRen) in place of the NSs gene (rMP12delNSs:hRen; see the supplemental
material). This reporter virus replicates efﬁciently in Aag2 cells although its replication
is slightly impaired compared to that of the parental MP12 (Fig. S1A). Correlation of
hRen activity with viral replication was conﬁrmed by comparison of luciferase enzyme
activity (expressed as light units) to hRenmRNA and viral N mRNA levels (Fig. S1B). Aag2
FIG 4 RVFV-speciﬁc piRNA-like small RNAs are produced in infected mosquitoes. (A to C) Representation of piRNA sequence logos within 28-nt reads. All reads
mapping to the RVFV MP12 genomic and antigenomic sequences were analyzed for their base frequencies at each position for RVFV-derived small-RNA reads
as previously described in Aag2 cells (Fig. 2A). A. aegypti data are presented in panel A, A. vexans data are shown in panel B, and C. quinquefasciatus data are
shown in panel C. (D to F) The panels show the probability of overlap at the 5= end of the opposite viral small RNA for the 28-nt reads. The x axis indicates
the number of nucleotides overlapping between the antigenomic and genomic sequences; the y axis shows the mean fractions of reads overlapping. A. aegypti
data are presented in panel D, A. vexans data are shown in panel E, and C. quinquefasciatus data are shown in panel F. (G to I) Alignment of the 28-nt small-RNA
reads to RVFV MP12 RNA segments as previously described for RVFV-derived small-RNA reads in Aag2 cells (Fig. 2C). The alignment of A. aegypti is presented
in panel G, that of A. vexans is shown in panel H, and that of C. quinquefasciatus is shown in in panel I.
Insect RNA Interference Responses against RVFV
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cells were transfected with dsRNAs against the RVFV L, M, and S segments prior to
infection with rMP12delNSs:hRen, and luciferase activity was measured 18 h p.i.
(Fig. 5B); targeting of dsRNAs to the RNA-dependent RNA polymerase and the N and
the hRen mRNAs, but not the M mRNA, led to a signiﬁcant reduction in RVFV
replication. The failure of dsRNA targeting the M segment to reduce RVFV replication
might reﬂect the fact that M segment gene products GC and Gn do not directly
participate in viral RNA replication and that viral replication can persist even under
conditions in which glycoprotein expression is diminished.
In summary, here we have shown that RVFV-derived small RNAs from Aag2 cells
were able to target homologous RNA fragments and are incorporated into the RISC,
thus demonstrating their functionality.
Antiviral effects of RNA interference in RVFV-infected Aag2 and S2 cells. Having
demonstrated the presence and functionality of RVFV-derived small RNAs, we next
analyzed the impact of silencing Ago2, a key component of the siRNA pathway, on
RVFV replication in Aag2 and S2 cells and adult D. melanogaster. Aag2 and S2 cells were
infected with the rMP12delNSs:hRen virus strain, as described above. Similarly to Aag2
cells, rMP12delNSs:hRen showed slightly impaired growth compared to rMP12 in S2
cells (Fig. S1C). Signiﬁcantly enhanced viral replication, indicated by increased luciferase
activity, was observed in Ago2 knockdowns in Aag2 and S2 cells (Fig. 6A and B). In
addition to the data generated with reporter virus, we conﬁrmed that RVFV MP12
replication was also enhanced following Ago2 knockdown (Fig. S1D). Silencing of Ago2
expression was veriﬁed by quantitative reverse transcription-PCR (qRT-PCR) in Aag2
cells (Fig. S1E) and Western blotting in S2 cells (Fig. S1F). With the ﬂy model system
established, we further analyzed the impact of Ago2 on RVFV infection in vivo. Wild-
type (WT) ﬂies (yw) and Ago2 null mutants were injected with RVFV MP12, and
replication and survival of ﬂies were measured. A signiﬁcant increase in the levels of
viral particles at day 5 after infection was observed in Ago2/ ﬂies (Fig. S2A).
Furthermore, the increased viral replication led to reduced survival of RVFV-infected
Ago2/ mutant ﬂies compared to mock-infected controls or RVFV-infected WT ﬂies
(Fig. S2B). Overall, these ﬁndings conﬁrm a general role for the exogenous siRNA in
insect antiviral responses to RVFV.
FIG 5 RVFV-derived small RNAs display antiviral properties. (A and B) The accessibility of RVFV mRNAs to
RVFV-speciﬁc small RNAs and their antiviral properties were investigated using luciferase reporter-based sensor
constructs (A) and RVFV-targeting dsRNAs (B), respectively. (A) Aag2 cells were either infected with RVFV MP12
(white bars) or left uninfected (black bars). At 24 h p.i., cells were transfected with small-RNA sensors (pIZ
containing a nanoluciferase [NLuc] ORF fused to RVFV-speciﬁc/control sequences) and a transfection control
(pIZ-FLuc). RVFV-speciﬁc sequences consisted of fragments ampliﬁed from the L open-reading frame (ORF; 515 nt),
the M ORF (529 nt), the N ORF (498 nt), or the 5= or 3= halves of the NSs ORF (NSs5=, 416 nt; NSs3=, 329 nt). Primer
binding sites for the respective fragments are indicated in Table S3. NLuc/FLuc ratios in transfected infected cells
were normalized against the respective transfected uninfected cells. The graph presents means and standard errors
of results from three independent experiments, each performed in triplicate. Statistical analysis was performed
using the t test. *, P  0.05. (B) dsRNAs targeting the RVFV rMP12delNSs:hRen L, M, and S segments (dsL, dsM, dsN,
dshRen) or a control dsRNA targeting eGFP (dsCon) were transfected into Aag2 cells, followed by virus infection.
Viral replication was measured by luciferase assay, and dsL, dsM, dsN, and dshRen transfected samples were
normalized against the control samples. The graph presents means and standard errors of results from three
independent experiments, each performed in triplicate. Statistical analysis was performed using the t test. *, P 
0.05.
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Since we observed signiﬁcant amounts of piRNAs in A. aegypti cells and whole
mosquitoes, we further analyzed the impact of the piRNA pathway on antiviral defense
by silencing of the pathway member proteins Piwi4, Piwi5, Piwi6, and Ago3 in Aag2
cells. Knockdown of Piwi4 and Ago3 led to an increase in viral replication, whereas
knockdown of Piwi5 and Piwi6 did not signiﬁcantly alter virus replication (Fig. 6C).
Silencing was conﬁrmed by qRT-PCR (Fig. S1G). These data suggest that the piRNA
pathway plays a role in anti-RVFV defense in A. aegypti-derived cells.
Does RVFV suppress RNAi? To determine whether RVFV encodes a suppressor of
RNAi, we assessed the ability of virus to prevent dsRNA-mediated knockdown of a
target mRNA (Fireﬂy luciferase [FLuc]) in Aag2 (Fig. 7A) and S2 (Fig. 7B) cells. In both our
assay systems, RVFV MP12 was unable to prevent dsRNA-based knockdown of the
target reporter mRNA. This was in contrast to Culex Y virus (CYV, Birnaviridae), previ-
ously shown to encode a VSR protein (25), which inhibited FLuc silencing in Aag2 cells
(Fig. 7A).
FIG 6 RNAi pathways limit replication of RVFV in A. aegypti and D. melanogaster cells. (A and B) Impact
of Ago2 knockdown on replication of RVFV rMP12delNSs:hRen in Aag2 cells (A) or D. melanogaster S2
cells (B). Knockdown of Ago2 was induced by transfection of dsRNA targeting the corresponding
sequence (A. aegypti dsAgo2 in panel A or D. melanogaster dsDmAgo2 in panel B). Cells transfected with
dsRNA targeting eGFP (dsCon) were used as controls. Viral replication was measured in dsAgo2-treated
Aag2 and S2 cells by luciferase assay; values were normalized against the respective dsCon-treated cells.
(A) The graph presents means and standard errors of results from ﬁve independent experiments
performed in triplicate. (B) The graph presents means and standard errors of results from four indepen-
dent experiments, each performed in sextuplicate. Statistical analysis was performed using the t test. *,
P  0.05. (C) Impact of Piwi4, Piwi5, Piwi6, and Ago3 knockdown on replication of RVFV rMP12delNSs:
hRen in Aag2 cells. Knockdown of Piwi4, Piwi5, Piwi6, and Ago3 was induced by transfection of dsRNA
targeting the corresponding sequence, and dsRNA targeting eGFP (dsCon) was used as a control. Viral
replication in dsPiwi4-, dsPiwi5-, dsPiwi6-, and dsAgo3-treated cells as measured by luciferase assay was
normalized against that in control (dsCon-treated) cells. The panel represents mean values and standard
errors of results from ﬁve independent experiments performed in triplicate. Statistical analysis was
performed using the t test. *, P  0.05.
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DISCUSSION
Previous ﬁndings have demonstrated that viral RNA is a target for exogenous siRNA
and piRNA pathways during RVFV ZH548 infection of mosquito cells (17). However,
neither the functional relevance of these small RNAs nor the transferability of the result
obtained in cells to whole mosquitoes has been demonstrated. In this study, we have
expanded our understanding of RVFV-insect interactions by analyzing small-RNA pro-
ﬁles from RVFV MP12-infected A. aegypti-derived Aag2 cells and three different vector
mosquito species (A. aegypti, A. vexans, and C. quinquefasciatus) as well as D. melano-
gaster-derived S2 cells. Furthermore, we tested the in vivo functionality of these small
RNAs by the use of different cell-based reporter assays and the model insect D. mela-
nogaster.
The viRNA proﬁles were derived from RVFV MP12-infected Aag2 cells, Aedes sp.
mosquitoes, and C. quinquefasciatus. Mosquitoes and D. melanogaster S2 cells showed
a large degree of similarity with regard to viRNA pattern and distribution but not with
regard to viRNA abundance. We observed remarkably fewer viRNAs in C. quinquefas-
ciatus mosquitoes than in Aedes sp. mosquitoes (see Table S1 in the supplemental
material). This may either point to a species-related difference in levels of viRNA
production efﬁciency (VPE) or be attributable to the infection status of individual
mosquitoes used for small-RNA deep sequencing (for A. vexans, mean threshold cycle
[CT] value of 21 and VPE level of 1.5% of total 21-nt fraction; for A. aegypti, mean CT
value of 26.6 and VPE level of 0.6%; for C. quinquefasciatus, mean CT value of 27.8 and
VPE level of 0.05%). Additional studies performed with viruses that target both Aedes
sp. and Culex sp. mosquitoes are needed to clarify whether there are species-speciﬁc
differences in levels of viRNA production. With regard to the viRNA pattern, the
segment coverage levels and small-RNA ratios are highly similar between the different
species tested and indicate that Dcr2-dependent dicing accounts for a considerable
proportion of viRNAs in RVFV-infected insect cells and mosquitoes. These ﬁndings are
in line with earlier small-RNA sequencing efforts in RVFV-infected Aag2 and S2 cells (17,
38) and in BUNV-infected Aag2 and Culicoides sonorensis KC cells (18) as well as with
observations made in alphavirus- and ﬂavivirus-infected insects (14, 16). Interestingly,
we observed a favoring of the M segment over the S segment despite the fact that the
FIG 7 RVFV does not interfere with the exogenous RNAi pathway in mosquito and D. melanogaster cells. (A and
B) The effect of RVFV MP12 protein expression on the induction of exogenous RNAi was analyzed using a FLuc
reporter system. (A) Aag2 cells were infected with RVFV MP12 or Culex Y virus (CYV) as a control or left uninfected
and subsequently transfected with luciferase expression plasmids (pIZ-FLuc as the reporter and pAct-Renilla as an
internal control) and dsRNA targeting either FLuc or eGFP control sequences. Values of speciﬁc luciferase activity
reduction were ﬁrst normalized against a transfection control, and additional speciﬁc FLuc dsRNA-transfected
samples were normalized against dseGFP-transfected controls. Effects of virus infection on RNAi induction are
presented as percent silencing compared to the noninfected cells. The graph presents means and standard errors
of results from three independent experiments performed in triplicate. Statistical analysis was performed using the
t test. *, P  0.05. (B) S2 cells were transfected with luciferase expression plasmids (pMT-Fluc as the reporter and
pMT-Rluc as an internal control) and dsRNA targeting either FLuc or eGFP as a control. Cells were then either
infected with RVFV MP12 or left uninfected. dsRNA targeting either FLuc or eGFP as a control was added to the cell
culture media. The expression of luciferase reporters was induced and quantiﬁed. Data were analyzed and
presented as described for panel A. The graph presents means and standard errors of results from three
independent experiments performed in sextuplicate. Statistical analysis was performed using the t test. *, P  0.05.
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S segment is the most abundant segment, at least in infected mammalian cells (L
segment/M segment/S segment ratios  1:3:13 [40]). With regard to segment favoring,
our data also contrast with previous observations made in BUNV-infected Aag2 and KC
cells, where the S segment is favored (18). The overrepresentation of M segment reads
in RVFV-infected cells and Aedes sp. mosquitoes and D. melanogaster indicates a
biological signiﬁcance of this pattern; however, the data are difﬁcult to interpret with
current knowledge, since the ratios of L, M, and S segments in insect cells have not
been analyzed. Furthermore, we observed the same bias toward the intergenic region
(IGR) previously reported by Sabin et al. (38) in S2 cells and also in mosquito cells and
adult mosquitoes. Interestingly, this bias was seen only for the antigenome IGR
sequence in S2 cells (reference 38 and our study) and C. quinquefasciatus, whereas it
was observed for both the genome and the antigenome in infected mosquito cells and
Aedes sp. mosquitoes. We speculate that hybridization of complementary N and NSs
mRNAs or their overlapping transcription termination signals (41–43) provides an easily
accessible Dcr2 substrate. In contrast, the partially double-stranded genomic panhan-
dle structures formed by the termini would require protection from Dcr2 degradation
in insect cells and are thus covered by N protein. The apparent differences between
species (ﬂy and C. quinquefasciatus mosquitoes versus Aedes sp. mosquitoes) or virus
strains (MP12 strain versus ZH548 [17]) may be due to tissue-speciﬁc effects present
under in vivo conditions but could also be due to viruses in multiple phases of
replication in live mosquitoes which could mask more-speciﬁc effects seen in the
relatively synchronized infection of cell lines. The possibility that in vivo targeting and
in vitro targeting function differently cannot be excluded at present, and future studies
need to take this into account. Alternatively, the conﬂict may have been due to
technical issues such as library preparation (44). Nonetheless, as sequencing was carried
out independently in two locations (Hamburg and Glasgow), we argue that this
targeting represents a real signature of viRNA production present during infection of
insect cells with RVFV MP12.
It has previously been speculated on the basis of superinfection exclusion assays
that small RNAs may mediate antiviral activity (17). Nonetheless, a direct demonstration
of an antiviral role of small-RNA pathways against RVFV has been missing, and our data
demonstrate a key role for the exogenous siRNA and piRNA pathways in controlling
virus replication. We show that RVFV cannot be targeted by artiﬁcially induced siRNAs
only and that infection produces virus-derived small RNAs with antiviral activity, that
Ago2, Piwi4, and Ago3 are involved in the antiviral response, and that RVFV is unable
to inhibit at least dsRNA-induced RNAi.
Given the availability of a number of well-characterized genetic D. melanogaster
models which allow in vivo studies and facilitate high-throughput studies for host factor
identiﬁcation (45–47), we used the fruit ﬂy to demonstrate that defects in the exoge-
nous RNAi pathway (speciﬁcally in Ago2) lead to increased viral replication and thus to
higher ﬂy mortality. This suggests a link between processing of small RNAs derived from
the RVFV RNA segments (17, 38) and antiviral defense in D. melanogaster.
In addition to the 21-nt viRNAs, virus-speciﬁc piRNA-like molecules of 24 to 30 nt in
length were detected in all RVFV-infected mosquitoes and cells but not in D. melano-
gaster cells. The presence of arboviral piRNA-like molecules in mosquitoes is in line with
previous reports of RVFV-infected mosquito cell lines (17), as well as other bunyaviruses
and alphaviruses (18, 22, 29, 30, 35, 48), whereas their absence in D. melanogaster has
been recently reported (49). Most characteristics of the RVFV-speciﬁc piRNA-like mol-
ecules are shared between all tested mosquitoes and the Aag2 cells, including the
unbalanced production across the different segments (M  S  L) and the bias toward
reads mapping to the M and S segment antigenomes. The preference for production of
piRNA-like reads matching the antigenome of negative-strand viruses has been previ-
ously reported for La Crosse virus (LACV, Bunyaviridae) in C6/36 cells (for all three
segments) and for RVFV ZH548 infection in different mosquito cells (only for the S
segment) (17, 30, 48). The bias of piRNA-like molecules mapping to the antigenome of
RVFV cannot be explained by the amount of antigenome versus genome during an
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infection, as recent research has shown that approximately 2.5-fold to 4.5-fold more
genome RNA than antigenome RNA is present during RVFV MP12 infection of different
cells (50). However, as stated above, it can be expected that viral mRNAs would be more
accessible to cytoplasmic components of RNAi pathways than encapsidated genomic/
antigenomic RNAs. It is difﬁcult to distinguish between the viral mRNA and antigenome
species in the case of the RVFV L and M segments in contrast to the ambisense S
segment. As recently shown, more N mRNA than NSs mRNA is present during RVFV
MP12 infection (50), which is in line with the bias of piRNAs mapping to the antigenome
of the N gene observed in infected mosquitoes and Aag2 cells at different time points.
However, a similar bias was not observed for RVFV ZH548 infection of Aag2 cells (17).
Whether this was due to experimental setup or strain-speciﬁc issues is not known at this
point. The production of these piRNA-like molecules during RVFV infection and the
increase of RVFV replication in Aag2 cells upon knockdown of Piwi4 and Ago3 strongly
support the idea of an antiviral function of the piRNA pathway in addition to the
exogenous siRNA pathway during RVFV infection of mosquitoes. Similar results have
been reported for the positive-strand alphaviruses (16, 22). Taking the data together, it
can be hypothesized that the mosquito piRNA pathway can target positive-strand and
negative-strand RNA arboviruses. The detection of RVFV-speciﬁc piRNA-like molecules
in infected C. quinquefasciatus mosquitoes suggests that the antiviral function of the
piRNA pathway is not restricted to Aedes sp. mosquitoes but can be extended to Culex
sp. mosquitoes.
In summary, we show that antiviral RNAi pathways—the exogenous siRNA pathway
and the piRNA pathway—are induced by RVFV infection across a number of vector
species and the ﬂy model and that RVFV is unable to prevent dsRNA-induced RNAi.
Thus, this segmented negative-strand RNA virus is very similar to positive-stranded RNA
arboviruses with respect to targeting by mosquito RNAi responses. The universal role
of RNAi pathways points to their importance in combating virus infection throughout
insects and makes them an attractive target for manipulation.
MATERIALS AND METHODS
Animal ethics statement. The Institut Pasteur de Dakar (IPD) has received authorization from the
Senegalese Ministry of Health to perform experiments on live animals in accordance with international
regulations, and policies governing the care and use of laboratory animals and the IPD are guided by the
International Guiding Principles for Biomedical Research Involving Animals developed by the Council for
International Organizations of Medical Sciences.
Tissue culture and virus production. BHK-21 cells were grown in Leibovitz (L-15) media or
Glasgow’s minimal essential medium (GMEM) supplemented with 10% calf serum, 100 U/ml penicillin,
and 100 g/ml streptomycin. Vero E6 cells were maintained in Leibovitz (L-15) media supplemented with
10% fetal calf serum, 100 U/ml penicillin, and 100 g/ml streptomycin. Cells were grown at 37°C in 5%
CO2. A. aegypti-derived Aag2 cells were grown in L-15 media supplemented with 10% fetal calf serum,
100 U/ml penicillin, 100 g/ml streptomycin, and 10% tryptose phosphate broth at 28°C. D. melanogaster
S2 cells were propagated in Schneider’s media supplemented with 10% fetal calf serum, 100 U/ml
penicillin, and 100 g/ml streptomycin at 28°C. Propagation of RVFV strain MP12 was performed on
BHK-21 cells at 33°C, unless stated otherwise, and virus titers were measured by plaque assay on Vero E6
cells (BNI) or BHK-21 cells (CVR).
Construction of an RVFV reporter virus and virus rescue. In order to monitor RVFV replication in
insect cells, a reporter virus expressing luciferase in place of the NSs ORF was constructed (51). To delete
the NSs gene in the RVFV MP12 S segment, plasmid pTVT7-GS (52) was used as the template in an
excision PCR (53), using outward-facing forward and reverse primers (see Table S3 in the supplemental
material). The PCR product generated lacked nucleotides 19 to 819 of the RVFV MP12 S segment and
possessed at its 3= end SpeI and KpnI restriction sites and at its 5= end KpnI and PmII sites. The PCR
product was digested with KpnI and religated to form plasmid pTVT7-GSΔNSs-KpnI. Digestion of
pTVT7-GSΔNSs-KpnI with PmlI and SpeI allowed directional insertion of humanized Renilla luciferase
(hRen) into the S segment in an ambisense orientation to generate pTVT7-GSΔNSs:hRen. The coding
sequence for hRen was ampliﬁed by PCR from phRL-CMV (phRL-cytomegalovirus) (Promega). Rescue of
the rMP12ΔNSs:hRen reporter virus was performed using a reverse genetics system described earlier (54).
Brieﬂy, 7  105 BSR-T7/5 cells were seeded in a T-25 ﬂask and left to adhere overnight. Cells were
transfected with expression plasmids pTM1-L (0.5 g) and pTM1-N (0.5 g) together with 1 g each of
transcription plasmids pTVT7-GL, pTVT7-GM, and pTVT7-GSΔNSs:hRen using Lipofectamine 2000 (Life
Technologies, Inc.). Virus-containing supernatant was harvested when extensive cytopathic effect was
observed in infected-cell monolayers (typically 5 to 7 days p.i.), clariﬁed by centrifugation, and stored at
80°C.
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Reporter virus characterization in Aag2 cells. rMP12delNSs:hRen growth curves were performed in
Aag2 cells. For this, 1.7  105 Aag2 cells per well were seeded in 24-well plates and left to adhere
overnight. Cells were infected at a multiplicity of infection (MOI) of 1, and virus growth was monitored
at the indicated time points by plaque assay, luciferase activity assay, and qRT-PCR. Plaque assays were
performed using cell supernatant as described above. Infected cell monolayers were lysed using passive
lysis buffer (Promega). Luciferase assays were performed using Renilla-Glo substrate (Promega) on a
GloMax luminometer. For qRT-PCR, cells were lysed in TRIzol reagent (Life Technologies, Inc.). qRT-PCRs
were performed to determine rMP12delNSs:hRen hRen and nucleocapsid (N) mRNA copy numbers in
infected Aag2 cells using random hexamer primers and a QuantiTect Probe PCR kit according to the
protocol of the manufacturer (Qiagen) with the following primers and probe: for hRen FP, hRen RP and
hRen probe (hRen); for RVF FP, RVF RP and RVF probe (RVFV N) (Table S3). A. aegypti ribosomal S7 was
ampliﬁed as an internal control using primers Aag-S7 FP and Aag-S7 RP and probe Aag-S7-Probe
(Table S3).
Mosquito maintenance and infections. A. aegypti (Linneaus) and C. quinquefasciatus (Say) labora-
tory strains (Bayer) were housed in environmental chambers with 25°C  2°C average temperature, 80%
relative humidity, and 12-h photoperiodicity. A. aegypti eggs were dried for 2 weeks before they were
ﬂoated in dechlorinated water. C. quinquefasciatus eggs were ﬂoated directly after deposition. Larvae
were kept in dechlorinated tap water and were fed on TetraMin baby ﬁsh food (Tetra). Fourth-instar
larvae were transferred into separate boxes and maintained in adult cages (Bioquip) (60 by 60 by 60 cm).
A sugar solution (10% fructose) was used as the carbohydrate source to feed adult mosquitoes. Female
mosquitoes were fed with human donor blood provided on a cotton patch, a method that has been
demonstrated to give results similar to those of membrane feeding in Culex species and Aedes species
mosquitoes (55). For infection experiments, 4-to-7-day-old females were separated into 175-ml plastic
tubes (Greiner Bio-One) and starved 24 h prior to provision of an infectious blood meal. The infectious
blood meal was offered on a cotton patch and contained 1 107 PFU/ml RVFV MP12 mixed with human
donor blood. Females were allowed to feed for 3 h at 28°C in the incubator. After feeding, fully engorged
females were sorted and kept for 14 days at 28°C and 80% humidity. To conﬁrm the positive infection
status of mosquitoes, one leg was removed and tested by RVFV L segment-speciﬁc qRT-PCR as described
below. Only females with CT values below 30 were kept for further analysis. The remaining bodies of
females with positive infection status (A. aegypti, n  10; C. quinquefasciatus, n  10) were pooled, and
total RNA was isolated using TRIzol reagent (Life Technologies, Inc.) according to the manufacturer’s
instructions.
A. vexansmosquitoes were collected from a ground pool in Barkédji village (15°17=N, 14°53=W), in the
Ferlo region of Senegal. The F1 generation adult mosquitoes used for the experimental infection were
reared in the laboratory under standard conditions at 27  1°C and a relative humidity of 70% to 75%
(56). RVFV MP12 strain viral stock was prepared and mosquito infections were performed as previously
described (57). Female mosquitoes (5 to 7 days old) were starved for 48 h prior to exposure to an
infectious blood meal for 1 h. The blood meal consisted of a 33% volume of washed rabbit erythrocytes,
a 33% volume of viral stock (1  108 PFU/ml), a 20% volume of fetal bovine serum (FBS), a 10% volume
of sucrose, 5 mM ATP, and 150 to 250 mg of sodium bicarbonate. The blood meal was administered using
chicken skins as membrane feeders. After feeding, a sample of remaining blood meal was stored at
80°C for titration. The mosquitoes were then cold anesthetized, and engorged mosquitoes were
incubated at 27°C, with relative humidity of 70% to 80%, and fed with 10% sucrose. At 15 days
postfeeding, mosquitoes were cold anesthetized. For each mosquito, legs and wings were removed and
collected in single tubes; bodies were stored in separate tubes. Samples were kept at 80°C until their
analysis. Leg and wing samples were screened by qRT-PCR for detection of virus using the following
procedure. Each mosquito’s legs and wings were titrated in 500 l of L-15 media supplemented with 10%
heat-inactivated fetal bovine serum, using a homogenizer. The suspensions were clariﬁed by centrifu-
gation (5,000  g for 10 min at 4°C), and the supernatant was used for RNA extraction with a QIAamp
viral RNA minikit (Qiagen), according to the manufacturer’s protocols. The RNA samples were screened
for RVFV presence by qRT-PCR using primers RVF FP and RVF RP and an RVF probe (Table S3). The
qRT-PCR assay was performed using an ABI 7500 cycler (Applied Biosystems) and a QuantiTect Probe
RT-PCR kit (Qiagen). A total of 11 bodies corresponding to infection-positive legs/wings with CT values
below 30 were pooled in TRIzol reagent for RNA extraction.
RVFV strain MP12 has been generated through serial passage on MRC-5 cells in the presence of
5-ﬂuorouacil, which generated mutations in all segments leading to attenuation of the virus in mam-
malian hosts, which may in part be linked to temperature sensitivity (58) However, previous studies have
demonstrated that there is no difference in the levels of virus replication and dissemination between
MP12 and virulent variant ZH501 in Culex pipiens mosquitoes (59).
Fly culture and infection. D. melanogaster strains yw and Ago2414 have been previously described
(60). The ﬂy stocks were raised on standard cornmeal-agar medium (Carolina) at 20°C. Adult ﬂies of 4 to
6 days of age were used for infection experiments. Infections were carried out by intrathoracic injection
(Nanoject II apparatus; Drummond Scientiﬁc) of 10 nl of a viral suspension (RVFV at 5  108 PFU/ml) in
cell culture media. Injection of the same volume of sterile cell culture media was used as a control.
Infected ﬂies were then incubated at 25°C on Nutri-Fly Bloomington Formulation (Flystuff).
RVF virus titration from infected ﬂies. Flies were collected at 5 days p.i., pooled (ﬁve specimens),
placed in sterile 1.5-ml tubes, and triturated in 500 l of cell culture medium (high-glucose Dulbecco’s
modiﬁed Eagle’s medium [Sigma-Aldrich]) containing 10% heat-inactivated fetal bovine serum, 100 U/ml
penicillin, and 100 g/ml streptomycin, using a tissue homogenizer. The suspensions were clariﬁed by
centrifugation (5,000  g for 1 min), and the supernatant was used for virus titration on Vero E6 cells.
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Small-RNA deep sequencing. Small-RNA sequencing from Aag2 cells and mosquitoes was carried
out by Edinburgh Genomics (University of Edinburgh) using an Illumina HighSeq 2000 platform and a
HighSeq 2500 platform, respectively, as previously described (18). Cells were either infected with RVFV
strain MP12 at a multiplicity of infection (MOI) of 5 or left uninfected. At 24 h p.i., RNA was isolated using
1 ml TRIzol reagent (Life Technologies, Inc.) per ﬂask followed by puriﬁcation.
Similarly, S2 cells were infected at an MOI of 1, and the small-RNA fraction was isolated 96 h p.i. using
a mirVana miRNA isolation kit (Ambion). The small-RNA fraction derived from puriﬁcation was further size
selected by fractionation on a 15% PAGE gel (7 M urea, 0.5 Tris-borate-EDTA [TBE]). RNAs (18 to 24
nucleotides in size) were excised using a RiboReady Colour Micro RNA ladder (Amresco) for size control
and eluted from gel overnight in 0.3 M NaCl buffer at 4°C with horizontal shaking (200 rpm). Puriﬁed
18-nt to 24-nt small-RNA fractions were suspended in 10 l H2O, and library preparation was performed
using an NEB Next Multiplex small RNA Library Prep Set for Illumina (New England Biolabs) according to
the manufacturer’s protocol. Sequencing was performed using a MiSeq reagent kit (v3) and an Illumina
MiSeq platform according to the manufacturer’s protocol.
Analysis of small-RNA reads was performed by the use of clipping adapters, and identical sequences
were collapsed using the fastx toolkit (http://hannonlab.cshl.edu/fastx_toolkit/). Reads were then aligned
to RVFV (NCBI accession numbers: for the L segment, DQ375404; for the M segment, DQ380208; for the
S segment, DQ380154) using BWA-backtrack (62). Length distributions of the reads and positioning on
the RVFV genome were analyzed using in-house perl (version 5.20.1) and R (63) (version 3.1.1) scripts. To
examine the preferred overlap between reads mapping on opposite strands, for each position of the
genomic strand, the numbers of reads on the antigenomic strand with overlaps of between 1 and 20
nucleotides were counted, normalized to 1, and summed up (weighted with the numbers of reads
mapping at the respective positions of the genomic strand).
In vitro dsRNA production. dsRNA molecules targeting A. aegypti Dcr2, Ago2, Piwi4, Piwi5, Piwi6,
and Ago3 and D. melanogaster Ago1 and Ago2 as well as eGFP were produced with a T7 RNA polymerase
in vitro transcription kit (Megascript RNAi kit; Ambion) using PCR products as the template. A. aegypti,
Ago2, Piwi4, Piwi5, Piwi6, and Ago3 PCR products were obtained from cDNA derived from Aag2 cell total
RNA. D. melanogaster Ago2 PCR products were generated from S2 cell total RNA. eGFP was ampliﬁed
from pEGFP-C1 (Clontech). Primers were used as described previously (18, 20, 22, 61).
Silencing of RNAi components. Aag2 cells were seeded at a density of 1.7 105 cells/well in 24-well
plates and left to adhere overnight. Cells were transfected with 300 ng of dsRNA targeting A. aegypti
Ago2 (dsAgo2), Piwi4 (dsPiwi4), Piwi5 (dsPiwi5), Piwi6 (dsPiwi6), and Ago3 (dsAgo3) using Lipofectamine
2000 (Life Technologies, Inc.) according to manufacturer’s speciﬁcations. dsRNA against eGFP (dseGFP)
was used as a control. At 24 h posttransfection (p.t.), cells were infected with recombinant RVFV
rMP12delNSs:hRen at an MOI of 0.1 (Ago2 knockdowns) or 0.01 (Piwi and Ago3 knockdowns). At 24 h p.i.
(Ago2 knockdowns) or 48 h p.i. (Piwi and Ago3 knockdowns), luciferase activity was determined using
Renilla-Glo substrate (Promega) on a GloMax luminometer following cell lysis in passive lysis buffer.
Knockdown of Ago2, Piwi4, Piwi5, Piwi6, and Ago3 was conﬁrmed by qRT-PCR as previously described
(18, 20). A. aegypti ribosomal S7 was used as an internal control for relative quantiﬁcations.
Similarly, Ago2 silencing was performed in S2 cells. S2 cells were seeded at a density of 5  104 in
96-well plates and left to adhere overnight. A 25-ng volume of dsRNA targeting D. melanogaster Ago2
(dsDmAgo2) (61) was then added to the cells. Infections and luciferase assays were performed as
described for Aag2 cells. Ago2 knockdown was conﬁrmed by immunoblotting using anti-Ago2/eIF2C2
(AB5072) antibodies (Abcam, Inc.). Actin was used as a loading control and detected using an anti-actin
antibody (clone JLA20; Millipore).
dsRNA-mediated silencing of RVFV. dsRNA molecules targeting rMP12delNSs:hRen or eGFP were
produced as described above. PCR products were generated using plasmids pTVT7-GL, pTVT7-GM, and
pTVT7-GS and primers dsL-Fwd and dsL-Rev, primers dsM-Fwd and dsM-Rev, and primers dsN-Fwd and
dsN-Rev, respectively (Table S3). The hRen dsRNA PCR template was ampliﬁed from pGL4.75 (Promega)
using primers dshRen-Fwd and dshRen-Rev (Table S3). Transfections of Aag2 cells were performed as
described above. At 4 h (p.t.), cells were infected with rMP12delNSs:hRen at an MOI of 0.1. At 18 h p.i.,
luciferase activity was determined using Renilla-Glo substrate (Promega) on a GloMax luminometer
following cell lysis in passive lysis buffer.
Small-RNA sensor assays. Small-RNA sensors were constructed by cloning nanoluciferase (NLuc)
cDNA into the pIZ vector (Life Technologies, Inc.) using HindIII and XbaI restriction sites. NLuc was
ampliﬁed from pNL1.1 vector (Promega) using primers Nanoluc-Fwd and Nanoluc-Rev (Table S3). RVFV
MP12 fragments were ampliﬁed from plasmids pTVT7-GL, pTVT7-GM, and pTVT7-GS and inserted
downstream of the NLuc ORF using XbaI and SacII restriction sites and the following primers: primers
RVFV L F XbaI and RVFV L R SacII; primers RVFV M Fwd XbaI and RVFV M Rev. Sac II; primers RVFV N
FwdXbaI and RVFV New Rev SacII; primers NSs5= F XbaI and NSs5= R SacII; and primers NSs3= F XbaI and
NSs3= R SacII (Table S3). RVFV-speciﬁc fragment lengths were as follows: for L ORF, 515 nt; for M ORF,
529 nt; for N ORF, 498 nt; for NSs ORF 5= half (NSs5=), 416 nt; for NSs ORF 3= half (NSs3=), 329 nt. Primer
binding sites for the respective fragments are indicated in Table S3. A fragment of the eGFP cDNA was
ampliﬁed from pEGFP-C1 (Clontech) using primers eGFP-XbaI-FW and eGFP-SacII-RV (Table S3) and
inserted into pIZ-NLuc using XbaI and SacII restriction sites. Aag2 cells (1.7  105 per well) were seeded
into 24-well plates and left to adhere overnight. Cells were either infected with RVFV MP12 at an MOI of
1 or left uninfected. At 24 h p.i., all cells were transfected with 200 ng of the different small-RNA sensors
using Lipofectamine 2000 transfection reagent. pIZ (100 ng) expressing Fireﬂy luciferase (pIZ-Fluc) (64,
65) was used as a transfection control. At 24 h p.i., NLuc and FLuc expression was measured using
Nano-Glo and Bright-Glo substrates (Promega).
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RNAi suppression assays. RNAi suppression assays were performed in both Aag2 and S2 cells. Aag2
cells (1.7  105 per well in a 24-well plate) were infected with RVFV MP12 or the positive-control CYV at
an MOI of 5 and incubated for 24 h at 28°C. Cells were then cotransfected with 100 ng pIZ-Fluc (64, 65),
40 ng pAct-Renilla (66) (FLuc and RLuc expression plasmids, respectively), and 0.05 ng dsRNA targeting
FLuc or a control dsRNA targeting eGFP using Lipofectamine 2000. At 24 h p.t., cells were lysed in passive
lysis buffer and FLuc and RLuc expression was determined using Bright-Glo and Renilla-Glo substrates
(Promega).
RNAi suppression assays in S2 cells have previously been described (67, 68). Brieﬂy, 5  104 S2 cells
were seeded in 96-well plates and left to adhere overnight. Cells were transfected with 50 ng pMT-Fluc
and 15 ng pMT-Rluc for 24 h at 28°C, after which the cells were either infected with RVFV MP12 at an MOI
of 5 for 24 h or left uninfected. A 25-ng volume of dsRNA targeting either FLuc or eGFP as a control was
fed to the cells. At 7 h after the feeding of dsRNA, expression of luciferase reporters was induced by
addition of 0.5 mM CuSO4 per well. After 24 h, cells were lysed and luciferase expression was determined
as described above.
Statistical analyses. All statistical analyses presented were performed using GraphPad Prism (ver-
sion 5; GraphPad Software, Inc., La Jolla, CA, USA). Survival analysis was carried out with the Kaplan-Meier
test and the log rank test. Statistical analyses of the data from dsRNA knockdown experiments and
small-RNA sensor and RNAi suppressor assays were performed using the t test. P value representations
for all tests are as follows: *, P  0.05; **, P  0.01; ***, P  0.001; ****, P  0.0001.
Accession number(s). Small RNA sequencing data have been deposited in the NCBI database under
accession no. PRJNA383480.
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